163 related articles for article (PubMed ID: 37569451)
21. Effects of the lncRNA MALAT1 gene region rs664589 site mutation on acute myocardial infarction in Chinese Han.
Yu H; Tu S; Shen C; Bai X; Sun J; Shi M; Li C; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):119-127. PubMed ID: 38372103
[TBL] [Abstract][Full Text] [Related]
22. Frequency of ST-segment elevation myocardial infarction, non-ST-segment myocardial infarction, and unstable angina: results from a Southwest Chinese Registry.
Li SY; Zhou MG; Ye T; Cheng LC; Zhu F; Cui CY; Zhang YM; Cai L
Rev Cardiovasc Med; 2021 Mar; 22(1):239-245. PubMed ID: 33792268
[TBL] [Abstract][Full Text] [Related]
23. Exosomal miR-152-5p and miR-3681-5p function as potential biomarkers for ST-segment elevation myocardial infarction.
Chen X; Huang F; Liu Y; Liu S; Tan G
Clinics (Sao Paulo); 2022; 77():100038. PubMed ID: 35751950
[TBL] [Abstract][Full Text] [Related]
24. Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome.
Li X; Yang Y; Wang L; Qiao S; Lu X; Wu Y; Xu B; Li H; Gu D
PLoS One; 2015; 10(5):e0125430. PubMed ID: 25933289
[TBL] [Abstract][Full Text] [Related]
25. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
[TBL] [Abstract][Full Text] [Related]
26. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
Jakob P; Kacprowski T; Briand-Schumacher S; Heg D; Klingenberg R; Stähli BE; Jaguszewski M; Rodondi N; Nanchen D; Räber L; Vogt P; Mach F; Windecker S; Völker U; Matter CM; Lüscher TF; Landmesser U
Eur Heart J; 2017 Feb; 38(7):511-515. PubMed ID: 28011706
[TBL] [Abstract][Full Text] [Related]
27. Nourin-Dependent miR-137 and miR-106b: Novel Biomarkers for Early Diagnosis of Myocardial Ischemia in Coronary Artery Disease Patients.
Elgebaly SA; Christenson RH; Kandil H; Ibrahim M; Rizk H; El-Khazragy N; Rashed L; Yacoub B; Eldeeb H; Ali MM; Kreutzer DL
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919942
[TBL] [Abstract][Full Text] [Related]
28. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Medicine (Baltimore); 2018 Jul; 97(27):e11428. PubMed ID: 29979444
[TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding RNA MALAT1 Promotes Acute Cerebral Infarction Through miRNAs-Mediated hs-CRP Regulation.
Teng L; Meng R
J Mol Neurosci; 2019 Nov; 69(3):494-504. PubMed ID: 31342266
[TBL] [Abstract][Full Text] [Related]
30. Association Between Plasma ADAMTS-9 Levels and Severity of Coronary Artery Disease.
Wei M; Pan H; Guo K
Angiology; 2021 Apr; 72(4):371-380. PubMed ID: 33307720
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
Lv F; Liu L; Feng Q; Yang X
J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
[TBL] [Abstract][Full Text] [Related]
32. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction.
Liu K; Tang Q; Zhu X; Yang X
Clin Chim Acta; 2017 May; 468():140-144. PubMed ID: 28237549
[TBL] [Abstract][Full Text] [Related]
33. Nationwide trends in acute coronary syndrome by subtype in New Zealand 2006-2016.
Wang TKM; Grey C; Jiang Y; Jackson RT; Kerr AJ
Heart; 2020 Feb; 106(3):221-227. PubMed ID: 31672778
[TBL] [Abstract][Full Text] [Related]
34. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.
Rizzacasa B; Morini E; Mango R; Vancheri C; Budassi S; Massaro G; Maletta S; Macrini M; D'Annibale S; Romeo F; Novelli G; Amati F
PLoS One; 2019; 14(5):e0216363. PubMed ID: 31059534
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Systemic and Culprit-Coronary Artery miR-483-5p Expression in Chronic CAD and Acute Myocardial Infarction Male Patients.
Volodko O; Volinsky N; Yarkoni M; Margalit N; Kusniec F; Sudarsky D; Elbaz-Greener G; Carasso S; Amir O
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239897
[TBL] [Abstract][Full Text] [Related]
36. Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final).
Ako J; Morino Y; Okuizumi K; Usami M; Nakamura M
Cardiovasc Interv Ther; 2016 Apr; 31(2):101-13. PubMed ID: 26449481
[TBL] [Abstract][Full Text] [Related]
37. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs.
Rognoni A; Cavallino C; Lupi A; Secco GG; Veia A; Bacchini S; Rosso R; Rametta F; Bongo AS
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1119-24. PubMed ID: 25160996
[TBL] [Abstract][Full Text] [Related]
38. Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results.
Varani E; Vecchio S; Aquilina M; Vecchi G; Balducelli M; Frassineti V; Margheri M
Minerva Cardioangiol; 2016 Feb; 64(1):23-33. PubMed ID: 26989947
[TBL] [Abstract][Full Text] [Related]
39. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
[TBL] [Abstract][Full Text] [Related]
40. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
